dihexa cancer risk hgf c-met Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk | Cell International dihexa c-met cancer risk Developing

Cagrilintide is an investigational compound , and current knowledge continues to evolve as additional clinical trial data becomes available

You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site

All products sold by French Peptides, a brand operated by Nova Lab Solutions LLC, a company registered in New Mexico (United States), are strictly intended for research, laboratory, and analytical purposes only

Signaling by hepatocyte growth factor in neurons is induced by pharmacological stimulation of synaptic activity

Competing interests None declared

Bunzel H